https://www.selleckchem.com/pr....oducts/coelenterazin
In this review, we discuss precursor-lesion specific targets of CRC and the current status of pre-clinical studies regarding clinical interventions and combinations for better efficacy and safety toward future precision clinical chemoprevention. In addition, we provide a brief discussion on the usefulness of secondary precision chemopreventive targets for tertiary precision chemoprevention to improve the disease-free and overall survival of advanced stage CRC patients.The majority of human prion diseases are sporadic, but acquire
Curtir
Comentario
Compartilhar
